Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical SettingsPasquale Lombardi, Gennaro Daniele|Cancers|2023Cited by 52
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse eventsEléonora De Martin, David J. Pinato, Claudia Angela Maria Fulgenzi et al.|Gut|2024Cited by 36
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a SignatureMarco Filetti, Manuela Petti, Alessio Cirillo et al.|Cancers|2024Cited by 3
1081P DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patientsMarco Filetti, Luca Farina, Mario Occhipinti et al.|Annals of Oncology|2022Cited by 0